ArticleTransplantation direct2024

The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation.

Claire Villeneuve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.